Sigma-Aldrich Corp (SIAL) 138.20 $SIAL
Sigma-Aldrich Q4 Earnings Top on Organic Sales Gain - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Feb 13, 9:08AM CST
Sigma-Aldrich's (SIAL) profit for fourth-quarter 2014 rose driven by higher sales across its business segments in the quarter, led by the SAFC Commercial unit.
DQ: 21.04 (-0.21), NL: 7.65 (+0.02), SIAL: 138.20 (+0.07), PENX: 18.87 (-0.01)
Sigma-Aldrich (SIAL) Beats Q4 Earnings and Revenue Estimates - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Feb 12, 6:35AM CST
Sigma-Aldrich (SIAL) Beats Q4 Earnings and Revenue Estimates
SIAL: 138.20 (+0.07)
Sigma-Aldrich declares $0.23 dividend
Seeking Alpha - at Seeking Alpha - Thu Feb 12, 5:25AM CST
SIAL: 138.20 (+0.07)
Sigma-Aldrich tops Street 4Q forecasts
Automated Insights - Thu Feb 12, 5:21AM CST
ST LOUIS (AP) _ Sigma-Aldrich Corp. (SIAL) on Thursday reported fourth-quarter profit of $133 million.
SIAL: 138.20 (+0.07)
Sigma-Aldrich (NASDAQ - SIAL) Reports Record Full-Year 2014 Sales Of $2.79 Billion And Record Adjusted Diluted EPS Of $4.37. Reports Q4 2014 Adjusted Diluted EPS Of $1.14 And Organic Sales Growth Of 7%. Declares $0.23 Per Share Quarterly Dividend.
PR Newswire - Thu Feb 12, 5:00AM CST
HIGHLIGHTS:
SIAL: 138.20 (+0.07)
Sigma-Aldrich Up 45.5% Since SmarTrend Uptrend Call (SIAL)
Comtex SmarTrend(R) - Wed Feb 11, 11:02AM CST
SmarTrend identified an Uptrend for Sigma-Aldrich (NASDAQ:SIAL) on April 2nd, 2014 at $95.00. In approximately 11 months, Sigma-Aldrich has returned 45.49% as of today's recent price of $138.22.
SIAL: 138.20 (+0.07)
International Flavors & Fragrances: Earnings Surprise Call? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Feb 10, 12:20PM CST
International Flavors & Fragrances Inc. (IFF) is scheduled to report fourth-quarter 2014 results on Feb 12 before the market opens. The Zacks Consensus Estimate for the quarter is pegged at $1.31.
IFF: 116.96 (+2.19), DQ: 21.04 (-0.21), SIAL: 138.20 (+0.07), MTX: 71.19 (+0.15)
Don't Miss Today's Strong And Under The Radar Stock: Sigma-Aldrich (SIAL)
at The Street - Tue Feb 10, 11:03AM CST
Trade-Ideas LLC identified Sigma-Aldrich (SIAL) as a strong and under the radar candidate
SIAL: 138.20 (+0.07)
Digging Deeper: Outperforming Stocks In The Lagging Materials Sector
Cerebro1 - at Seeking Alpha - Mon Feb 09, 2:47PM CST
XLB: 51.44 (+0.43), SIAL: 138.20 (+0.07), MWV: 53.91 (+0.59), SHW: 285.00 (+1.98)
Global Gas Chromatography Market 2014-2019: Instrumentation, Consumables & Accessories & by Reagents Analysis
M2 - Thu Feb 05, 3:01AM CST
Research and Markets (http://www.researchandmarkets.com/research/977d65/gas) has announced the addition of the "Gas Chromatography Market by Instrumentation, Consumables & Accessories & by Reagents - Analysis & Global forecast to 2019" report to their offering. The global gas chromatography market, valued at $2.58 billion in 2014, is expected to reach $3.60 billion by 2019 at a CAGR of 6.9% Chromatography has evolved over the years and become a method of choice for analysis, identification, and purification of a wide variety of compounds. The gas chromatography market has seen an extraordinary amount of technological advancements in the last few years, as companies have introduced new systems that perform chromatographic procedures in a lesser amount of time and provide more detailed results. This report categorizes the market into three broad segments, namely, Instrumentation, Accessories & Consumables, and Reagents. The market for gas chromatography instrumentation is segmented into systems, detectors, auto-samplers and fraction collectors. Systems account for the largest share of the instrumentation market. This segment is expected to grow at the highest CAGR of 5.7% from 2014 to reach $883.5 million by 2019. The gas chromatography market, by accessories & consumables, is broadly categorized into columns, column accessories, auto-sampler accessories, flow management consumables & accessories, fittings & tubing, mobile phase accessories, pressure regulators, and others. Increased importance of chromatography in drug approvals is likely to drive the growth of this market. Biotechnology and pharmaceutical industries are the prime users of chromatography techniques. The global gas chromatography market is dominated by North America, followed by Europe, Asia, and the Rest of the World (RoW). North America will continue to lead the market in the forecast period, followed by Europe. Over the next five years, the growth of the market in the Asian region is likely to be centered at China, India, Singapore, Malaysia, Vietnam, and Japan. This growth will be driven by factors such as the increasing number of conferences related to chromatography in Singapore and Malaysia, and the expansion of chromatography companies in China, India, Singapore, Vietnam, and Japan. Major players in the market include Agilent Technologies (U.S.), PerkinElmer (U.S.), Phenomenex, Inc. (U.S.), Shimadzu Corporation (Japan), Thermo Fisher Scientific, Inc. (U.S.), and W.R. Grace & Co. (U.S.). Key Topics Covered: 1 Introduction 2 Research Methodology 3 Executive Summary 4 Premium Insights 5 Market Overview 6 Industry Insights 7 Gas Chromatography Market, By Product 8 Gas Chromtography Market, By Consumables & Accessories 9 Gas Chromatography Market, By Reagents 10 Gas Chromatography Market, By Application 11 Gas Chromatography Market, By Geography 12 Competitive Landscape 13 Company Profiles - Agilent Technologies - Emd Millipore/ Merck Millipore (A Division of Merck Kgaa) - Pall Corporation - Perkinelmer, Inc - Phenomenex, Inc. - Restek Corporation - Shimadzu Corporation - Sigma-Aldrich Corporation - Thermo Fisher Scientific, Inc - W.R.Grace & Co For more information visit http://www.researchandmarkets.com/research/977d65/gas
PLL: 103.00 (+0.14), A: 40.15 (+0.13), SIAL: 138.20 (+0.07), MRK: 58.81 (-0.07), PKI: 46.30 (-0.10)
Sigma-Aldrich Has Returned 44.9% Since SmarTrend Recommendation (SIAL)
Comtex SmarTrend(R) - Wed Feb 04, 9:38AM CST
SmarTrend identified an Uptrend for Sigma-Aldrich (NASDAQ:SIAL) on April 2nd, 2014 at $95.00. In approximately 10 months, Sigma-Aldrich has returned 44.94% as of today's recent price of $137.69.
SIAL: 138.20 (+0.07)
Is Sigma-Aldrich (SIAL) Poised to Beat on Earnings in Q4? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Feb 03, 11:10AM CST
Sigma-Aldrich (SIAL) is expected to release its fourth-quarter 2014 results on Feb 5, 2015.
CCJ: 15.67 (+0.25), DQ: 21.04 (-0.21), SIAL: 138.20 (+0.07), CMP: 91.66 (+0.52)
Dividend Aristocrats And A Fundamental Principle Of Dividend Growth Investing
Brian Ditchek - at Seeking Alpha - Tue Feb 03, 10:01AM CST
MKC: 74.64 (+0.33), GPC: 97.01 (+0.22), CAH: 86.08 (+0.04), ED: 63.92 (-1.69), SYY: 39.54 (-0.12), WMT: 85.81 (-0.08), GWW: 234.87 (+0.56), PNR: 66.87 (+1.09), TGT: 76.12 (-0.75), ABBV: 58.05 (+1.00), LOW: 72.05 (-0.14), BCR: 175.38 (+0.50), TROW: 82.45 (+0.17), VFC: 75.26 (+4.26), FDO: 77.86 (+0.31), HRL: 55.73 (+1.56), MHFI: 102.19 (unch), ADP: 88.75 (+1.00), ADM: 48.10 (+0.66), SIAL: 138.20 (+0.07), MCD: 95.65 (+0.56), DOV: 74.41 (+1.13), CVX: 112.78 (+1.92), SHW: 285.00 (+1.98), BF.B: 90.72 (-0.28), MMM: 165.94 (+0.03), BDX: 143.71 (+0.72), CLX: 109.00 (+0.74), MDT: 75.26 (+0.33), KMB: 111.00 (+0.82), XOM: 93.37 (+1.00), CB: 102.06 (+0.43), PEP: 99.13 (-1.14), SWK: 98.20 (+0.92), JNJ: 99.62 (+1.18), T: 34.66 (+0.05), CINF: 52.46 (+0.27), PPG: 236.77 (+3.74), APD: 152.81 (+0.59), ECL: 111.62 (+0.85), KO: 41.99 (-0.18), ABT: 46.09 (+0.87), HCP: 42.87 (+0.20), NUE: 48.90 (+0.55), EMR: 58.68 (+0.08), LEG: 44.90 (+0.17), ITW: 98.26 (+0.48), CTAS: 81.64 (-0.57), PG: 85.90 (-0.13), BEN: 53.91 (+0.23), AFL: 62.13 (+0.33), CL: 70.08 (+0.23)
Tracking Yacktman Asset Management Portfolio - Q4 2014 Update
John Vincent - at Seeking Alpha - Tue Feb 03, 4:03AM CST
BDX: 143.71 (+0.72), CHRW: 72.58 (+0.75), CLX: 109.00 (+0.74), SYY: 39.54 (-0.12), XOM: 93.37 (+1.00), WMT: 85.81 (-0.08), PDCO: 50.65 (-0.16), PEP: 99.13 (-1.14), ANTM: 141.05 (-0.95), JNJ: 99.62 (+1.18), FOX: 33.66 (+0.35), EBAY: 56.47 (+1.73), FOXA: 34.72 (+0.31), MSFT: 43.87 (+0.78), NWS: 16.41 (+0.05), BK: 39.20 (-0.21), CSCO: 29.43 (-0.03), SYK: 94.51 (+1.14), KO: 41.99 (-0.18), AVP: 9.08 (+0.39), STT: 76.93 (-0.46), BCR: 175.38 (+0.50), UN: 42.28 (-0.30), COP: 69.88 (+1.84), WFC: 55.33 (+0.47), HPQ: 38.56 (+0.19), ORCL: 43.93 (+0.04), USB: 45.07 (-0.05), SIAL: 138.20 (+0.07), MRK: 58.81 (-0.07), PG: 85.90 (-0.13), VIAB: 68.98 (+1.27), CMCSA: 59.47 (+1.09)
Epigenetics Market by Product, Research Area & by End User - Global Forecast to 2019 with Abcam, Active Motif, Diagenode, EMD Millipore, Illumina, New England Biolabs & QIAGEN Dominating
M2 - Mon Feb 02, 3:06AM CST
Research and Markets (http://www.researchandmarkets.com/research/658vm2/epigenetics) has announced the addition of the "Epigenetics Market by Product, Research Area & by End User - Global Forecast to 2019" report to their offering. The global epigenetics market was valued at an estimated $413.24 million in 2014. This market is expected to grow at a CAGR of 13.64% between 2014 and 2019 and it is expected to be valued at $783.17 million in 2019 Epigenetics is the most widely used technique for cancer research. A large quantity of products such as kits and reagents are required for cancer research. Oncology is the largest research area for the market in 2014. According to GLOBOCAN, in 2012, there were 14.1 million new cancer cases, 8.2 million cancer deaths, and 32.6 million people living with cancer (within five years of diagnosis) in 2012 globally. The rapid growth in cancer prevalence, and resultant research interest in oncology, will be primary drivers for the epigenetics market between 2014 and 2019. The product segments of the epigenetics market included in this report are enzymes, instruments & consumables, kits, and reagents. The enzymes product segment is further subsegmented into DNA-modifying enzymes (DNA ligases, DNA polymerases and other DNA-modifying enzymes); protein-modifying enzymes (acetylases, methyltransferases and other protein-modifying enzymes); and RNA-modifying enzymes (reverse transcriptases, RNA ligases, and other RNA-modifying enzymes). The instruments & consumables product segment is further subsegmented into mass spectrometers; next-generation sequencers;qPCRs; sonicators; and other epigenetics instruments & consumables. The kits product segment is further subsegmented into bisulfite conversion kits; ChIP-seq kits; RNA sequencing kits; whole genome amplification kits; 5-hmC & 5-mC analysis kits; and other epigenetics kits. The reagents product segment is further subsegmented into antibodies; buffers; histones; magnetic beads; primers; and other reagents. Epigenetics finds applications in a large number of research areas of life sciences. On the basis of research areas, the report is segmented into developmental biology; drug discovery; oncology; and other epigenetics research areas. On the basis of end users, the global market report is segmented into academic research institutes; biotechnology and pharmaceutical companies; and contract research organizations. The major players in the global epigenetics market include Abcam (U.K.), Active Motif (U.S.), Diagenode (Belgium), EMD Millipore (U.S.), Illumina (U.S.), New England Biolabs (U.S.), QIAGEN (Netherlands Key Topics Covered: 1 Introduction 2 Research Methodology 3 Executive Summary 4 Premium Insights 5 Market Overview 6 Industry Insights 7 Epigenetics Market, By Product 8 Epigenetics Market, By Research Areas 9 Epigenetics Market, By End User 10 Geographic Analysis 11 Competitive Landscape 12 Company Profiles - Abcam - Active Motif - Diagenode - Illumina - Merck - New England Biolabs - Qiagen - Sigma-Aldrich Corporation - Thermo Fisher Scientific - Zymo Research For more information visit http://www.researchandmarkets.com/research/65...pigenetics
SIAL: 138.20 (+0.07), MRK: 58.81 (-0.07)
Protein Characterization and Identification Market by Instruments, Consumables & Services, Application, & by End Users - Global Forecast to 2019
M2 - Fri Jan 30, 11:42PM CST
Research and Markets (http://www.researchandmarkets.com/research/8mr9p9/protein) has announced the addition of the "Protein Characterization and Identification Market by Instruments, Consumables & Services, Application, & by End Users - Global Forecast to 2019" report to their offering. The global protein characterization and identification market was valued at $1.56 billion in 2014, and is expected to grow at a CAGR of 10.63% to reach $2.6 billion in 2019 The marketing automation software is a sales and marketing tool that helps the company to nurture leads with their likes and dislikes and turn the customers into delighted customers. The software understands the leads behaviour and on that behaviour do scoring and converting into quality leads to the sales team. The software broadly focuses on range of automation and analytic tool for sales and marketing activities through multiple online channels. The major factors that is driving the Marketing Automation Software market is the need of marketing accountability, third-party application ecosystem, and growth in multiple online channels is enhancing the market globally. These drivers are creating demand of the software across various verticals. The major factors which are restricting the growth of Marketing Automation Software market are open source solution, technology shift, and data privacy. Furthermore there are even few challenges like providing customer specific solution to every organisation. There are various assumptions that have been taken into consideration for market sizing and forecasting exercise. Few of global assumptions include political, economic, social, technological and economic factors. For instance, economic factor such as exchange rates are expected to have a moderate rating of impact on this market. Therefore, dollar fluctuations are not expected to seriously affect the forecasts in the emerging APAC and LA regions. Key Topics Covered: 1 Introduction 2 Research Methodology 3 Executive Summary 4 Premium Insights 5 Market Overview 6 Industry Insights 7 Protein Characterization and Identification Market, By Application 8 Protein Characterization and Identification Market, By Product 9 Protein Characterization and Identification Market, By End User 10 Geographic Analysis 11 Competitive Landscape 12 Company Profiles - Agilent Technologies, Inc. - Bio-Rad Laboratories, Inc. - Bruker Corporation - Danaher Corporation - General Electric - Perkinelmer, Inc. - Shimadzu Corporation - Sigma-Aldrich Corporation - Thermo Fisher Scientific - Waters Corporation For more information visit http://www.researchandmarkets.com/research/8mr9p9/protein
A: 40.15 (+0.13), SIAL: 138.20 (+0.07), DHR: 86.81 (+0.21), WAT: 119.86 (+0.71)
Cell Expansion Market by Product , Cell Type, Application, End User - Forecast to 2019
M2 - Fri Jan 30, 11:35PM CST
Research and Markets (http://www.researchandmarkets.com/research/br25h6/cell_expansion) has announced the addition of the "Cell Expansion Market by Product , Cell Type, Application, End User - Forecast to 2019" report to their offering. The global cell expansion market is expected to reach $14.8 billion by 2019 from $6.0 billion in 2014, growing at a CAGR of 19.7% from 2014 to 2019. The cell expansion market is segmented on the basis of product, cell type, application, end-user, and geography. On the basis of product, the cell expansion market is segmented into consumables and instruments. In 2014, the consumables segment is expected to account for the largest share of the global cell expansion market, by product. The high share can be attributed to the extensive requirement of media in cell expansion process. The consumables market is further divided into reagents, media and serum, and disposables. The instrument market is segmented into automated cell expansion systems, bioreactors and supporting equipment. Supporting equipment include centrifuges, flow cytometers, filtration systems, incubators, microscopes, laminar air flow cabinets and others. The others segment includes strainers, water baths, vortex mixers, pipettes, and cell counters. The bioreactors segment is further categorized into micro carrier bioreactor and perfusion or hollow fiber bioreactors. The cell expansion market by cell type is bifurcated into human cells and animal cells. The human cell market is further sub segmented into stem cells and differentiated cells. The stem cell expansion market is poised to witness the highest growth in the cell expansion market, by cell type, owing to the increasing government funding of stem cell research and investments by companies to boost the research in cancer. The cell expansion market, by application is classified into cancer and stem cell research, regenerative medicine, biotechnology and biopharmaceutical and clinical diagnostics; while the cell expansion market, by end-user is divided into research institutes, hospitals and diagnostic laboratories, cell banks, and biotechnology and biopharmaceutical companies. The global cell expansion market is dominated by North America, followed by Europe, Asia, and Rest of the World (RoW). North America will continue to lead the global cell expansion market in the forecast period, followed by Europe. Over the next five years, the growth of the global cell expansion market in the Asian region is likely to be centered on China, Japan, and India. Key Topics Covered: 1 Introduction 2 Research Methodology 3 Executive Summary 4 Premium Insights 5 Market Overview 6 Industry Trends 7 Cell Expansion Market, By Product 8 Cell Expansion Market, By Cell Type 9 Cell Expansion Market, By Application 10 Cell Expansion Market, By End User 11 Cell Expansion Market, By Geography 12 Competitive Landscape 13 Company Profiles - Beckman Coulter (Subsidiary of Danaher Corporation) - Becton Dickinson and Company - Corning Incorporated - Ge Healthcare (A Fully Owned Subsidiary of General Electric Company) - Merck Millipore (A Segment of Merck Kgaa) - Miltenyi Biotec - Sigma-Aldrich Corporation - Stemcell Technologies - Terumo BCT (A Subsidiary of Terumo Corporation) - Thermo Fisher Scientific, Inc. For more information visit http://www.researchandmarkets.com/research/br..._expansion
GE: 25.15 (+0.26), SIAL: 138.20 (+0.07), MRK: 58.81 (-0.07), DHR: 86.81 (+0.21)
Sigma-Aldrich® and the Institute of Molecular Genetics, Czech Center for Phenogenomics, Establish CRISPR Core Lab Collaboration
PR Newswire - Thu Jan 29, 6:00AM CST
Sigma-Aldrich Corporation's (NASDAQ: SIAL) Research business unit, which supports scientific research by supplying products, services and solutions, today announced it has entered into a new gene editing collaboration with the Institute of Molecular Genetics (IMG) at the Czech Center for Phenogenomics (CCP) in Prague. Under the collaboration, Sigma-Aldrich will provide the Transgenic Module at IMG/CCP with Sigma CRISPR technology, including reagents, experimental design consultation and dedicated gene editing bioinformaticians.
SIAL: 138.20 (+0.07)
Shares of SIAL Up 44.8% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Wed Jan 28, 9:14AM CST
SmarTrend identified an Uptrend for Sigma-Aldrich (NASDAQ:SIAL) on April 2nd, 2014 at $95.00. In approximately 10 months, Sigma-Aldrich has returned 44.80% as of today's recent price of $137.56.
SIAL: 138.20 (+0.07)
Sigma-Aldrich Allies with VIB to Provide Research Tools - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Jan 26, 1:40PM CST
Sigma-Aldrich (SIAL) has partnered with VIB to enhance commercialization and supply of research tools.
ASH: 127.58 (+1.21), GSM: 15.60 (+0.06), SIAL: 138.20 (+0.07), MTX: 71.19 (+0.15)
Sigma-Aldrich Q4 Earnings Top on Organic Sales Gain - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Feb 13, 9:08AM CST
Sigma-Aldrich's (SIAL) profit for fourth-quarter 2014 rose driven by higher sales across its business segments in the quarter, led by the SAFC Commercial unit.
DQ: 21.04 (-0.21), NL: 7.65 (+0.02), SIAL: 138.20 (+0.07), PENX: 18.87 (-0.01)
Sigma-Aldrich (SIAL) Beats Q4 Earnings and Revenue Estimates - Tale of the Tape
Zacks Equity Research - Zacks Investment Research - Thu Feb 12, 6:35AM CST
Sigma-Aldrich (SIAL) Beats Q4 Earnings and Revenue Estimates
SIAL: 138.20 (+0.07)
Sigma-Aldrich declares $0.23 dividend
Seeking Alpha - at Seeking Alpha - Thu Feb 12, 5:25AM CST
SIAL: 138.20 (+0.07)
Sigma-Aldrich tops Street 4Q forecasts
Automated Insights - Thu Feb 12, 5:21AM CST
ST LOUIS (AP) _ Sigma-Aldrich Corp. (SIAL) on Thursday reported fourth-quarter profit of $133 million.
SIAL: 138.20 (+0.07)
Sigma-Aldrich (NASDAQ - SIAL) Reports Record Full-Year 2014 Sales Of $2.79 Billion And Record Adjusted Diluted EPS Of $4.37. Reports Q4 2014 Adjusted Diluted EPS Of $1.14 And Organic Sales Growth Of 7%. Declares $0.23 Per Share Quarterly Dividend.
PR Newswire - Thu Feb 12, 5:00AM CST
HIGHLIGHTS:
SIAL: 138.20 (+0.07)
Sigma-Aldrich Up 45.5% Since SmarTrend Uptrend Call (SIAL)
Comtex SmarTrend(R) - Wed Feb 11, 11:02AM CST
SmarTrend identified an Uptrend for Sigma-Aldrich (NASDAQ:SIAL) on April 2nd, 2014 at $95.00. In approximately 11 months, Sigma-Aldrich has returned 45.49% as of today's recent price of $138.22.
SIAL: 138.20 (+0.07)
International Flavors & Fragrances: Earnings Surprise Call? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Feb 10, 12:20PM CST
International Flavors & Fragrances Inc. (IFF) is scheduled to report fourth-quarter 2014 results on Feb 12 before the market opens. The Zacks Consensus Estimate for the quarter is pegged at $1.31.
IFF: 116.96 (+2.19), DQ: 21.04 (-0.21), SIAL: 138.20 (+0.07), MTX: 71.19 (+0.15)
Don't Miss Today's Strong And Under The Radar Stock: Sigma-Aldrich (SIAL)
at The Street - Tue Feb 10, 11:03AM CST
Trade-Ideas LLC identified Sigma-Aldrich (SIAL) as a strong and under the radar candidate
SIAL: 138.20 (+0.07)
Digging Deeper: Outperforming Stocks In The Lagging Materials Sector
Cerebro1 - at Seeking Alpha - Mon Feb 09, 2:47PM CST
XLB: 51.44 (+0.43), SIAL: 138.20 (+0.07), MWV: 53.91 (+0.59), SHW: 285.00 (+1.98)
Global Gas Chromatography Market 2014-2019: Instrumentation, Consumables & Accessories & by Reagents Analysis
M2 - Thu Feb 05, 3:01AM CST
Research and Markets (http://www.researchandmarkets.com/research/977d65/gas) has announced the addition of the "Gas Chromatography Market by Instrumentation, Consumables & Accessories & by Reagents - Analysis & Global forecast to 2019" report to their offering. The global gas chromatography market, valued at $2.58 billion in 2014, is expected to reach $3.60 billion by 2019 at a CAGR of 6.9% Chromatography has evolved over the years and become a method of choice for analysis, identification, and purification of a wide variety of compounds. The gas chromatography market has seen an extraordinary amount of technological advancements in the last few years, as companies have introduced new systems that perform chromatographic procedures in a lesser amount of time and provide more detailed results. This report categorizes the market into three broad segments, namely, Instrumentation, Accessories & Consumables, and Reagents. The market for gas chromatography instrumentation is segmented into systems, detectors, auto-samplers and fraction collectors. Systems account for the largest share of the instrumentation market. This segment is expected to grow at the highest CAGR of 5.7% from 2014 to reach $883.5 million by 2019. The gas chromatography market, by accessories & consumables, is broadly categorized into columns, column accessories, auto-sampler accessories, flow management consumables & accessories, fittings & tubing, mobile phase accessories, pressure regulators, and others. Increased importance of chromatography in drug approvals is likely to drive the growth of this market. Biotechnology and pharmaceutical industries are the prime users of chromatography techniques. The global gas chromatography market is dominated by North America, followed by Europe, Asia, and the Rest of the World (RoW). North America will continue to lead the market in the forecast period, followed by Europe. Over the next five years, the growth of the market in the Asian region is likely to be centered at China, India, Singapore, Malaysia, Vietnam, and Japan. This growth will be driven by factors such as the increasing number of conferences related to chromatography in Singapore and Malaysia, and the expansion of chromatography companies in China, India, Singapore, Vietnam, and Japan. Major players in the market include Agilent Technologies (U.S.), PerkinElmer (U.S.), Phenomenex, Inc. (U.S.), Shimadzu Corporation (Japan), Thermo Fisher Scientific, Inc. (U.S.), and W.R. Grace & Co. (U.S.). Key Topics Covered: 1 Introduction 2 Research Methodology 3 Executive Summary 4 Premium Insights 5 Market Overview 6 Industry Insights 7 Gas Chromatography Market, By Product 8 Gas Chromtography Market, By Consumables & Accessories 9 Gas Chromatography Market, By Reagents 10 Gas Chromatography Market, By Application 11 Gas Chromatography Market, By Geography 12 Competitive Landscape 13 Company Profiles - Agilent Technologies - Emd Millipore/ Merck Millipore (A Division of Merck Kgaa) - Pall Corporation - Perkinelmer, Inc - Phenomenex, Inc. - Restek Corporation - Shimadzu Corporation - Sigma-Aldrich Corporation - Thermo Fisher Scientific, Inc - W.R.Grace & Co For more information visit http://www.researchandmarkets.com/research/977d65/gas
PLL: 103.00 (+0.14), A: 40.15 (+0.13), SIAL: 138.20 (+0.07), MRK: 58.81 (-0.07), PKI: 46.30 (-0.10)
Sigma-Aldrich Has Returned 44.9% Since SmarTrend Recommendation (SIAL)
Comtex SmarTrend(R) - Wed Feb 04, 9:38AM CST
SmarTrend identified an Uptrend for Sigma-Aldrich (NASDAQ:SIAL) on April 2nd, 2014 at $95.00. In approximately 10 months, Sigma-Aldrich has returned 44.94% as of today's recent price of $137.69.
SIAL: 138.20 (+0.07)
Is Sigma-Aldrich (SIAL) Poised to Beat on Earnings in Q4? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Tue Feb 03, 11:10AM CST
Sigma-Aldrich (SIAL) is expected to release its fourth-quarter 2014 results on Feb 5, 2015.
CCJ: 15.67 (+0.25), DQ: 21.04 (-0.21), SIAL: 138.20 (+0.07), CMP: 91.66 (+0.52)
Dividend Aristocrats And A Fundamental Principle Of Dividend Growth Investing
Brian Ditchek - at Seeking Alpha - Tue Feb 03, 10:01AM CST
MKC: 74.64 (+0.33), GPC: 97.01 (+0.22), CAH: 86.08 (+0.04), ED: 63.92 (-1.69), SYY: 39.54 (-0.12), WMT: 85.81 (-0.08), GWW: 234.87 (+0.56), PNR: 66.87 (+1.09), TGT: 76.12 (-0.75), ABBV: 58.05 (+1.00), LOW: 72.05 (-0.14), BCR: 175.38 (+0.50), TROW: 82.45 (+0.17), VFC: 75.26 (+4.26), FDO: 77.86 (+0.31), HRL: 55.73 (+1.56), MHFI: 102.19 (unch), ADP: 88.75 (+1.00), ADM: 48.10 (+0.66), SIAL: 138.20 (+0.07), MCD: 95.65 (+0.56), DOV: 74.41 (+1.13), CVX: 112.78 (+1.92), SHW: 285.00 (+1.98), BF.B: 90.72 (-0.28), MMM: 165.94 (+0.03), BDX: 143.71 (+0.72), CLX: 109.00 (+0.74), MDT: 75.26 (+0.33), KMB: 111.00 (+0.82), XOM: 93.37 (+1.00), CB: 102.06 (+0.43), PEP: 99.13 (-1.14), SWK: 98.20 (+0.92), JNJ: 99.62 (+1.18), T: 34.66 (+0.05), CINF: 52.46 (+0.27), PPG: 236.77 (+3.74), APD: 152.81 (+0.59), ECL: 111.62 (+0.85), KO: 41.99 (-0.18), ABT: 46.09 (+0.87), HCP: 42.87 (+0.20), NUE: 48.90 (+0.55), EMR: 58.68 (+0.08), LEG: 44.90 (+0.17), ITW: 98.26 (+0.48), CTAS: 81.64 (-0.57), PG: 85.90 (-0.13), BEN: 53.91 (+0.23), AFL: 62.13 (+0.33), CL: 70.08 (+0.23)
Tracking Yacktman Asset Management Portfolio - Q4 2014 Update
John Vincent - at Seeking Alpha - Tue Feb 03, 4:03AM CST
BDX: 143.71 (+0.72), CHRW: 72.58 (+0.75), CLX: 109.00 (+0.74), SYY: 39.54 (-0.12), XOM: 93.37 (+1.00), WMT: 85.81 (-0.08), PDCO: 50.65 (-0.16), PEP: 99.13 (-1.14), ANTM: 141.05 (-0.95), JNJ: 99.62 (+1.18), FOX: 33.66 (+0.35), EBAY: 56.47 (+1.73), FOXA: 34.72 (+0.31), MSFT: 43.87 (+0.78), NWS: 16.41 (+0.05), BK: 39.20 (-0.21), CSCO: 29.43 (-0.03), SYK: 94.51 (+1.14), KO: 41.99 (-0.18), AVP: 9.08 (+0.39), STT: 76.93 (-0.46), BCR: 175.38 (+0.50), UN: 42.28 (-0.30), COP: 69.88 (+1.84), WFC: 55.33 (+0.47), HPQ: 38.56 (+0.19), ORCL: 43.93 (+0.04), USB: 45.07 (-0.05), SIAL: 138.20 (+0.07), MRK: 58.81 (-0.07), PG: 85.90 (-0.13), VIAB: 68.98 (+1.27), CMCSA: 59.47 (+1.09)
Epigenetics Market by Product, Research Area & by End User - Global Forecast to 2019 with Abcam, Active Motif, Diagenode, EMD Millipore, Illumina, New England Biolabs & QIAGEN Dominating
M2 - Mon Feb 02, 3:06AM CST
Research and Markets (http://www.researchandmarkets.com/research/658vm2/epigenetics) has announced the addition of the "Epigenetics Market by Product, Research Area & by End User - Global Forecast to 2019" report to their offering. The global epigenetics market was valued at an estimated $413.24 million in 2014. This market is expected to grow at a CAGR of 13.64% between 2014 and 2019 and it is expected to be valued at $783.17 million in 2019 Epigenetics is the most widely used technique for cancer research. A large quantity of products such as kits and reagents are required for cancer research. Oncology is the largest research area for the market in 2014. According to GLOBOCAN, in 2012, there were 14.1 million new cancer cases, 8.2 million cancer deaths, and 32.6 million people living with cancer (within five years of diagnosis) in 2012 globally. The rapid growth in cancer prevalence, and resultant research interest in oncology, will be primary drivers for the epigenetics market between 2014 and 2019. The product segments of the epigenetics market included in this report are enzymes, instruments & consumables, kits, and reagents. The enzymes product segment is further subsegmented into DNA-modifying enzymes (DNA ligases, DNA polymerases and other DNA-modifying enzymes); protein-modifying enzymes (acetylases, methyltransferases and other protein-modifying enzymes); and RNA-modifying enzymes (reverse transcriptases, RNA ligases, and other RNA-modifying enzymes). The instruments & consumables product segment is further subsegmented into mass spectrometers; next-generation sequencers;qPCRs; sonicators; and other epigenetics instruments & consumables. The kits product segment is further subsegmented into bisulfite conversion kits; ChIP-seq kits; RNA sequencing kits; whole genome amplification kits; 5-hmC & 5-mC analysis kits; and other epigenetics kits. The reagents product segment is further subsegmented into antibodies; buffers; histones; magnetic beads; primers; and other reagents. Epigenetics finds applications in a large number of research areas of life sciences. On the basis of research areas, the report is segmented into developmental biology; drug discovery; oncology; and other epigenetics research areas. On the basis of end users, the global market report is segmented into academic research institutes; biotechnology and pharmaceutical companies; and contract research organizations. The major players in the global epigenetics market include Abcam (U.K.), Active Motif (U.S.), Diagenode (Belgium), EMD Millipore (U.S.), Illumina (U.S.), New England Biolabs (U.S.), QIAGEN (Netherlands Key Topics Covered: 1 Introduction 2 Research Methodology 3 Executive Summary 4 Premium Insights 5 Market Overview 6 Industry Insights 7 Epigenetics Market, By Product 8 Epigenetics Market, By Research Areas 9 Epigenetics Market, By End User 10 Geographic Analysis 11 Competitive Landscape 12 Company Profiles - Abcam - Active Motif - Diagenode - Illumina - Merck - New England Biolabs - Qiagen - Sigma-Aldrich Corporation - Thermo Fisher Scientific - Zymo Research For more information visit http://www.researchandmarkets.com/research/65...pigenetics
SIAL: 138.20 (+0.07), MRK: 58.81 (-0.07)
Protein Characterization and Identification Market by Instruments, Consumables & Services, Application, & by End Users - Global Forecast to 2019
M2 - Fri Jan 30, 11:42PM CST
Research and Markets (http://www.researchandmarkets.com/research/8mr9p9/protein) has announced the addition of the "Protein Characterization and Identification Market by Instruments, Consumables & Services, Application, & by End Users - Global Forecast to 2019" report to their offering. The global protein characterization and identification market was valued at $1.56 billion in 2014, and is expected to grow at a CAGR of 10.63% to reach $2.6 billion in 2019 The marketing automation software is a sales and marketing tool that helps the company to nurture leads with their likes and dislikes and turn the customers into delighted customers. The software understands the leads behaviour and on that behaviour do scoring and converting into quality leads to the sales team. The software broadly focuses on range of automation and analytic tool for sales and marketing activities through multiple online channels. The major factors that is driving the Marketing Automation Software market is the need of marketing accountability, third-party application ecosystem, and growth in multiple online channels is enhancing the market globally. These drivers are creating demand of the software across various verticals. The major factors which are restricting the growth of Marketing Automation Software market are open source solution, technology shift, and data privacy. Furthermore there are even few challenges like providing customer specific solution to every organisation. There are various assumptions that have been taken into consideration for market sizing and forecasting exercise. Few of global assumptions include political, economic, social, technological and economic factors. For instance, economic factor such as exchange rates are expected to have a moderate rating of impact on this market. Therefore, dollar fluctuations are not expected to seriously affect the forecasts in the emerging APAC and LA regions. Key Topics Covered: 1 Introduction 2 Research Methodology 3 Executive Summary 4 Premium Insights 5 Market Overview 6 Industry Insights 7 Protein Characterization and Identification Market, By Application 8 Protein Characterization and Identification Market, By Product 9 Protein Characterization and Identification Market, By End User 10 Geographic Analysis 11 Competitive Landscape 12 Company Profiles - Agilent Technologies, Inc. - Bio-Rad Laboratories, Inc. - Bruker Corporation - Danaher Corporation - General Electric - Perkinelmer, Inc. - Shimadzu Corporation - Sigma-Aldrich Corporation - Thermo Fisher Scientific - Waters Corporation For more information visit http://www.researchandmarkets.com/research/8mr9p9/protein
A: 40.15 (+0.13), SIAL: 138.20 (+0.07), DHR: 86.81 (+0.21), WAT: 119.86 (+0.71)
Cell Expansion Market by Product , Cell Type, Application, End User - Forecast to 2019
M2 - Fri Jan 30, 11:35PM CST
Research and Markets (http://www.researchandmarkets.com/research/br25h6/cell_expansion) has announced the addition of the "Cell Expansion Market by Product , Cell Type, Application, End User - Forecast to 2019" report to their offering. The global cell expansion market is expected to reach $14.8 billion by 2019 from $6.0 billion in 2014, growing at a CAGR of 19.7% from 2014 to 2019. The cell expansion market is segmented on the basis of product, cell type, application, end-user, and geography. On the basis of product, the cell expansion market is segmented into consumables and instruments. In 2014, the consumables segment is expected to account for the largest share of the global cell expansion market, by product. The high share can be attributed to the extensive requirement of media in cell expansion process. The consumables market is further divided into reagents, media and serum, and disposables. The instrument market is segmented into automated cell expansion systems, bioreactors and supporting equipment. Supporting equipment include centrifuges, flow cytometers, filtration systems, incubators, microscopes, laminar air flow cabinets and others. The others segment includes strainers, water baths, vortex mixers, pipettes, and cell counters. The bioreactors segment is further categorized into micro carrier bioreactor and perfusion or hollow fiber bioreactors. The cell expansion market by cell type is bifurcated into human cells and animal cells. The human cell market is further sub segmented into stem cells and differentiated cells. The stem cell expansion market is poised to witness the highest growth in the cell expansion market, by cell type, owing to the increasing government funding of stem cell research and investments by companies to boost the research in cancer. The cell expansion market, by application is classified into cancer and stem cell research, regenerative medicine, biotechnology and biopharmaceutical and clinical diagnostics; while the cell expansion market, by end-user is divided into research institutes, hospitals and diagnostic laboratories, cell banks, and biotechnology and biopharmaceutical companies. The global cell expansion market is dominated by North America, followed by Europe, Asia, and Rest of the World (RoW). North America will continue to lead the global cell expansion market in the forecast period, followed by Europe. Over the next five years, the growth of the global cell expansion market in the Asian region is likely to be centered on China, Japan, and India. Key Topics Covered: 1 Introduction 2 Research Methodology 3 Executive Summary 4 Premium Insights 5 Market Overview 6 Industry Trends 7 Cell Expansion Market, By Product 8 Cell Expansion Market, By Cell Type 9 Cell Expansion Market, By Application 10 Cell Expansion Market, By End User 11 Cell Expansion Market, By Geography 12 Competitive Landscape 13 Company Profiles - Beckman Coulter (Subsidiary of Danaher Corporation) - Becton Dickinson and Company - Corning Incorporated - Ge Healthcare (A Fully Owned Subsidiary of General Electric Company) - Merck Millipore (A Segment of Merck Kgaa) - Miltenyi Biotec - Sigma-Aldrich Corporation - Stemcell Technologies - Terumo BCT (A Subsidiary of Terumo Corporation) - Thermo Fisher Scientific, Inc. For more information visit http://www.researchandmarkets.com/research/br..._expansion
GE: 25.15 (+0.26), SIAL: 138.20 (+0.07), MRK: 58.81 (-0.07), DHR: 86.81 (+0.21)
Sigma-Aldrich® and the Institute of Molecular Genetics, Czech Center for Phenogenomics, Establish CRISPR Core Lab Collaboration
PR Newswire - Thu Jan 29, 6:00AM CST
Sigma-Aldrich Corporation's (NASDAQ: SIAL) Research business unit, which supports scientific research by supplying products, services and solutions, today announced it has entered into a new gene editing collaboration with the Institute of Molecular Genetics (IMG) at the Czech Center for Phenogenomics (CCP) in Prague. Under the collaboration, Sigma-Aldrich will provide the Transgenic Module at IMG/CCP with Sigma CRISPR technology, including reagents, experimental design consultation and dedicated gene editing bioinformaticians.
SIAL: 138.20 (+0.07)
Shares of SIAL Up 44.8% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Wed Jan 28, 9:14AM CST
SmarTrend identified an Uptrend for Sigma-Aldrich (NASDAQ:SIAL) on April 2nd, 2014 at $95.00. In approximately 10 months, Sigma-Aldrich has returned 44.80% as of today's recent price of $137.56.
SIAL: 138.20 (+0.07)
Sigma-Aldrich Allies with VIB to Provide Research Tools - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Mon Jan 26, 1:40PM CST
Sigma-Aldrich (SIAL) has partnered with VIB to enhance commercialization and supply of research tools.
ASH: 127.58 (+1.21), GSM: 15.60 (+0.06), SIAL: 138.20 (+0.07), MTX: 71.19 (+0.15)
